Theoria Medical
Private Equity Round in 2024
Theoria Medical is a patient-centered healthcare company that offers a range of services designed to meet the needs of various stakeholders in the U.S. healthcare system, including post-acute care facilities, hospital systems, emergency medical services providers, and payers. Theoria Medical specializes in remote patient monitoring and chronic care management, while also providing telemedicine solutions, medical directorship, and on-site rounding. The company utilizes machine learning for medical management and offers proprietary electronic health record software to enhance operational efficiency and patient outcomes. By focusing on comprehensive care pathways, Theoria Medical aims to improve the quality of care delivered across the continuum of healthcare services.
Genetics & IVF Institute
Acquisition in 2024
Genetics & IVF Institute, based in Fairfax, Virginia, is a medical practice specializing in infertility treatment and genetics care. It operates an outpatient fertility clinic, providing a range of services including fertility treatments, genetics services, egg freezing, donor egg IVF, and embryology services. The Institute's mission is to help patients preserve their fertility and build their families through advanced reproductive technologies.
Aliiance Clinical Network
Acquisition in 2023
Aliiance Clinical Network offer marketing and maintenance services for developing new clinical research sites.
Minds + Assembly
Private Equity Round in 2023
Minds + Assembly is a creative agency specializing in the healthcare sector, offering a range of services that include marketing, digital advertising, and design. The company focuses on brand and campaign development, providing comprehensive support from initial brand launches to the execution of creative advertising campaigns. With an emphasis on design and strategic positioning, Minds + Assembly leverages advanced omnichannel capabilities to enhance brand visibility and engagement. Additionally, the agency incorporates data and analytics services to inform its strategies and optimize campaign effectiveness.
Unlock Health
Acquisition in 2023
Unlock Health is a strategic growth platform developer that focuses on delivering a comprehensive range of services to healthcare organizations. The company offers advertising, social media management, campaign management, marketing analytics, and contract modeling, among other solutions. By combining these services with advanced technology capabilities, Unlock Health acts as a full-service agency and managed care consultancy. This approach enables healthcare providers to address immediate growth challenges while also fostering sustainable performance for the long term. Through its tailored offerings, Unlock Health aims to support healthcare organizations in navigating the complexities of the industry and achieving their growth objectives.
Eruptr
Acquisition in 2023
Eruptr LLC is a digital marketing service provider based in Lakewood Ranch, Florida, established in 2009. The company specializes in delivering a comprehensive range of services, including search engine marketing, search engine optimization, social media marketing, banner advertising, and remarketing solutions. Eruptr serves a diverse clientele, including hospitals, healthcare systems, legal professionals, political advocacy groups, non-profits, and various businesses at local, national, and international levels. With a focus on patient engagement, Eruptr manages over 1,000 marketing campaigns monthly, targeting qualified patients seeking treatment options. By fostering direct relationships with major healthcare providers, the company aims to enhance brand awareness and drive measurable results for its clients.
United Vein Centers
Acquisition in 2022
United Vein Centers is an acute care center that focuses on offering primary healthcare and specialty services to its patients
Remedy Health Media
Acquisition in 2021
Remedy Health Media is a digital health platform that provides health-related information to consumers and caregivers in the United States. Established in 1994 and headquartered in New York, the company publishes various health magazines, including Diabetes Focus and MediZine's Healthy Living, as well as digital resources like Healthcommunities.com, which features a symptom checker and expert Q&A. Remedy Health Media aims to empower patients and caregivers by offering accessible content, tools, and authentic community interactions with health professionals. Additionally, it publishes Remedy, which shares insights from health experts, and RemedyKids, focused on children's health information. The company's products and services are designed to help individuals navigate the healthcare landscape more effectively, ultimately contributing to improved health outcomes. Publications are distributed through retail partners, pharmacy counters, and doctors' offices.
SSI Strategy
Private Equity Round in 2021
SSI Strategy is a management consulting firm that specializes in supporting life science companies, particularly in the areas of medical affairs, pharmacovigilance, and clinical development. Founded in 2010 and headquartered in Parsippany, New Jersey, the firm operates additional offices in Cambridge, Massachusetts; London, United Kingdom; New York, New York; and San Francisco, California. SSI Strategy offers a range of services, including global medical affairs transformation, competency model development, post-merger integration, launch preparation, and enhancements to pharmacovigilance systems. The firm also focuses on medical planning and prioritization of tactics to aid clients in navigating pharmaceutical product life cycles and ensuring business continuity in critical safety and quality activities. By combining business acumen with medical, clinical, and pharmacovigilance expertise, SSI Strategy delivers tailored solutions to meet the unique needs of its clients in the life sciences sector.
US Fertility
Private Equity Round in 2021
US Fertility is a physician-owned and physician-led practice management firm specializing in the fertility sector across the United States. The company provides a comprehensive suite of business support services to top-tier fertility programs, focusing on enhancing operational efficiency and patient care. By leveraging advanced technology platforms, US Fertility effectively manages clinical and business information systems, as well as other essential functions such as finance, legal, and lab operations. Their commitment to innovation and best practices aims to improve treatment outcomes and the overall patient experience. With a strong emphasis on collaboration, US Fertility supports both domestic and international fertility practices, ensuring they can deliver exceptional care to their patients.
SSI Strategy
Private Equity Round in 2020
SSI Strategy is a management consulting firm that specializes in supporting life science companies, particularly in the areas of medical affairs, pharmacovigilance, and clinical development. Founded in 2010 and headquartered in Parsippany, New Jersey, the firm operates additional offices in Cambridge, Massachusetts; London, United Kingdom; New York, New York; and San Francisco, California. SSI Strategy offers a range of services, including global medical affairs transformation, competency model development, post-merger integration, launch preparation, and enhancements to pharmacovigilance systems. The firm also focuses on medical planning and prioritization of tactics to aid clients in navigating pharmaceutical product life cycles and ensuring business continuity in critical safety and quality activities. By combining business acumen with medical, clinical, and pharmacovigilance expertise, SSI Strategy delivers tailored solutions to meet the unique needs of its clients in the life sciences sector.
Open Health
Acquisition in 2018
OPEN Health is a healthcare agency specializing in market access strategies and communications. The company offers a diverse range of services, including health economic modeling, patient engagement, real-world evidence, data analytics, and medical affairs consultancy. With a team of approximately 200 professionals, OPEN Health collaborates with leading pharmaceutical companies, as well as various medical device and healthcare delivery organizations, ranging from startups to large multinationals. By integrating scientific expertise with creative and digital solutions, the agency aims to enhance healthcare marketing and support organizations in focusing on their core functions.
Children's Choice Pediatric Dental Care
Acquisition in 2018
Children's Choice Pediatric Dental Care is a provider of comprehensive dental treatment and oral services tailored for children. The practice emphasizes quality care and engages with young patients through various offerings, which include oral health exams for infants, dental cleaning, and nutritional counseling. Additionally, the facility provides therapeutic and orthodontic care, sedation options, and oral surgery. The company's focus is on helping children maintain good oral hygiene at home and encouraging regular checkups to ensure ongoing dental health.
Peloton Advantage
Private Equity Round in 2018
Peloton Advantage, LLC is a medical communications company based in Parsippany, New Jersey, founded in 2005. The firm specializes in strategic publication planning and content development for medical education programs, offering services that include strategic communication plans, enduring content, and live events. Peloton Advantage has established itself as a leader in the industry, employing over 80 professionals who support both U.S. and global accounts for a diverse range of pharmaceutical, biotechnology, and medical device companies. The company's expertise spans various therapeutic areas, including cardiovascular disease, infectious disease, and rare diseases, contributing to the success of more than 90 products. Peloton Advantage has received multiple awards for its growth and industry impact, reflecting its commitment to delivering high-quality medical communications.
SynteractHCR
Acquisition in 2016
SynteractHCR Holdings Corp. is a full-service contract research organization based in Carlsbad, California, established in 2008. With over two decades of experience, it supports biotechnology, medical device, and pharmaceutical companies throughout all phases of clinical development. The company emphasizes a collaborative approach through its “Shared Work – Shared Vision” philosophy, enabling it to provide customized services from Phase I to Phase IV efficiently and cost-effectively. Operating in 16 countries, SynteractHCR conducts international clinical trials and offers expertise in various therapeutic areas, including oncology, central nervous system disorders, infectious diseases, endocrinology, cardiovascular, and respiratory conditions, ensuring timely delivery of quality data to facilitate faster decision-making for its clients.